Safety Study of Interferon Beta 1a to for Acute Stroke

Completed

Phase 1 Results

Summary of Purpose

This study will examine the safety of the drug interferon beta 1a in patients with acute ischemic stroke to determine the highest dose patients can tolerate without serious side effects and to determine the best way to give the medication. Ischemic stroke is caused by a blood clot blocking the flow of blood to brain tissue, causing loss or impairment of bodily functions governed by the affected part of the brain....

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 June 2017.

17 Nov 2004 20 Nov 2004 Unavailable 8 Apr 2011 8 Apr 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Purpose: Treatment

Contacts

  • Lisa Davis, RN, MSN, CCRC Senior Nurse Specialist NINDS, Section on Stroke Diagnostics and Therapeutics 10 Center Drive Building 10, Room B1D733 Bethesda, MD 20892-1063 Phone: 301-435-7659 Fax: 301-480-0418 email: davisl@NINDS.nih.gov

    davisl@NINDS.nih.gov